HEALTH Zycov-D, India’s first COVID-19 vaccine for those above 12, gets approval The Drugs Controller General of India approved Zydus Cadila's (Zycov-D)three-dose COVID-19 DNA vaccine for emergency-use authorization.
HEALTH Zydus Cadila applies for emergency use nod for COVID-19 vaccine The pace of the second wave of coronavirus in the country is now slowing down. The country is being vaccinated rapidly amid fears of a third wave of the pandemic. Drug maker Zydus Cadila on Thursday sought approval for the emergency use of its vaccine.
CURRENT AFFAIRS Zydus Cadila's COVID-19 Vaccine Candidate Found Safe In Human Trial Now the company will start a mid-stage trial of the vaccine candidate, ZyCoV-D, in over 1,000 healthy adult volunteers. The trial will start from Thursday to test its effectiveness, it said in a regulatory filing.
/dnp-english/media/agency_attachments/2024/11/25/2024-11-25t064936166z-dnp-india-logo-640x480-dnp-news-2.png){kind=logo}